BillionToOne (BLLN) Stock Price Today & Analysis
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
About BillionToOne
BillionToOne is recognized for transforming healthcare through its redefinition of molecular diagnostics. The company’s revolutionary single-molecule NGS (smNGS) platform achieves what was once considered impossible — the detection and precise quantification of genetic targets with single-molecule sensitivity. At the core of this breakthrough is BillionToOne’s patented QCT technology, which enables measurements at the physical limit of detection — the single DNA molecule. This innovation directly addresses a long-standing challenge in healthcare: the difficulty of detecting sparse yet clinically critical disease signals in cell-free DNA (cfDNA).
